Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRX-100 in Healthy Adults in a Human Influenza A Challenge Model
NCT07503405Phase 2Not yet recruiting
- Sponsor
- Traws Pharma, Inc.
- Start
- Jun 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tivoxavir marboxil in influenza, sponsored by Traws Pharma, Inc.. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tivoxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07503405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07503405.